Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV casopitant with ondansetron and dexamethasone for prevention of oxaliplatin-induced nausea and vomiting
2007-005169-36Phase 3Completed
- Sponsor
- GSK
- Start
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of casopitant in Nausea and Vomiting (2 arms), sponsored by GSK. Primary endpoint: Complete response in overall phase. Started Dec 2007; status: completed.
02
Drugs
casopitant
03
Conditions
Nausea and Vomiting
Beyond the preview
Go deeper on 2007-005169-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005169-36.